IndraLab

Statements

reach
"Lithium chloride (LiCl, 1 mM), gabapentin (100 muM), valproate (100 muM), and carbamazepine (100 muM) increased TREK-1 currents by 31 +/- 14%, 25 +/- 11%, 28 +/- 12%, and 72 +/- 12%, respectively, whereas they had no effect on TREK-2 channel activity."
29156592
reach
"Application of LiCl (1 mM), gabapentin (100 muM), valproate (100 muM), and carbamazepine (100 muM) significantly activated TREK-1 by 31 +/- 14%, 25 +/- 11%, 28 +/- 12%, and 42 +/- 12%, respectively (n = 5, p < 0.05, XREF_FIG a, c)."
29156592
reach
"The activation of TREK-1 by LiCl, gabapentin, valproate, and carbamazepine was reversible and dose dependent."
29156592